Durvalumab trials for Extensive-stage Small-cell Lung Cancer

All Durvalumab trials · All Extensive-stage Small-cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Durvalumab for Extensive-stage Small-cell Lung Cancer

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
  NCT07005128 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 164 locations
• A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
  NCT07459634 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
  NCT06223711 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
  NCT05068232 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
  NCT05903092 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many trials study Durvalumab for Extensive-stage Small-cell Lung Cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.